Tapewire

NYSE · USD

LLY

ELI LILLY & Co

Export transactions ↓
Tapewire entity
2794
SEC CIK
0000059478
Parsed reports
2,757

Last 12 months

Inside the activity.

0 purchase rows · 240 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250200
Dec 202503
Jan 2026031
Feb 202600
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 20, 2025 Filed Nov 21, 2025 21:00 UTC SaleCommon Stock 3,702 $1,053.52 $3,900,138.44
Disclosure

SEC source: 0000316011-25-000083 · form4-11212025_041101.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,611,157

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,053.00 to $1,053.98, inclusive.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 21:00 UTC SaleCommon Stock 6,047 $1,052.55 $6,364,739.62
Disclosure

SEC source: 0000316011-25-000083 · form4-11212025_041101.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,614,859

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,052.00 to $1,052.999, inclusive.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 21:00 UTC SaleCommon Stock 6,701 $1,051.37 $7,045,250.47
Disclosure

SEC source: 0000316011-25-000083 · form4-11212025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,620,906

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,051.00 to $1,051.993, inclusive.

Read SEC document
November 20, 2025 Filed Nov 21, 2025 21:00 UTC SaleCommon Stock 16,845 $1,050.36 $17,693,381.58
Disclosure

SEC source: 0000316011-25-000083 · form4-11212025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,627,607

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,050.00 to $1,050.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), and (6) to this Form 4.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 1,206 $1,055.08 $1,272,427.69
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,644,452

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,055.00 to $1,055.54, inclusive.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 6,109 $1,054.48 $6,441,836.65
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,645,658

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,054.00 to $1,054.996, inclusive.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 13,820 $1,053.47 $14,559,010.68
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,651,767

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,053.00 to $1,053.993, inclusive.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 21,107 $1,052.54 $22,215,898.46
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,665,587

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,052.00 to $1,052.999, inclusive.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 28,768 $1,051.43 $30,247,653.31
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,686,694

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,051.00 to $1,051.999, inclusive.

Read SEC document
November 19, 2025 Filed Nov 20, 2025 21:00 UTC SaleCommon Stock 96,516 $1,050.21 $101,361,875.33
Disclosure

SEC source: 0000316011-25-000081 · form4-11202025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,715,462

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,050.00 to $1,050.999, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), and (6) to this Form 4.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 980 $1,039.61 $1,018,817.80
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,811,978

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,039.21 to $1,040.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 3,950 $1,038.48 $4,101,996.00
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,812,958

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,038.03 to $1,038.94, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 2,424 $1,037.38 $2,514,606.70
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,816,908

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,037.02 to $1,038.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 8,067 $1,036.58 $8,362,058.59
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,819,332

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,036.02 to $1,037.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 13,097 $1,035.50 $13,561,956.60
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,827,399

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,035.02 to $1,036.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 12,198 $1,034.65 $12,620,685.10
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,840,496

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,034.02 to $1,035.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 6,380 $1,033.50 $6,593,710.86
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,852,694

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,033.02 to $1,034.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 7,208 $1,032.64 $7,443,233.08
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,859,074

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,032.02 to $1,033.01, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 1,605 $1,031.41 $1,655,419.47
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,866,282

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,031.00 to $1,031.91, inclusive.

Read SEC document
November 18, 2025 Filed Nov 19, 2025 21:00 UTC SaleCommon Stock 4,304 $1,030.32 $4,434,484.37
Disclosure

SEC source: 0000316011-25-000079 · form4-11192025_041102.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,867,887

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,030.00 to $1,030.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:16 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0000059478-25-000258 · wk-form4_1763500557.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,988.689

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:16 UTC GrantCommon Stock 9.706 $1,021.70 $9,916.62
Disclosure

SEC source: 0000059478-25-000258 · wk-form4_1763500557.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,773.362

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:19 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0000059478-25-000260 · wk-form4_1763500742.xml · nonDerivative · entry 1

JACKSON JAMERE · CIK 0001601813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,635.494

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:23 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0000059478-25-000264 · wk-form4_1763501018.xml · nonDerivative · entry 2

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,704.141

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:23 UTC GrantCommon Stock 14.518 $1,021.70 $14,833.04
Disclosure

SEC source: 0000059478-25-000264 · wk-form4_1763501018.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,488.814

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:25 UTC GrantCommon Stock 233.271 $1,021.70 $238,332.98
Disclosure

SEC source: 0000059478-25-000266 · wk-form4_1763501099.xml · nonDerivative · entry 1

Moeller Jon R · CIK 0001450613 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304.271

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:39 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0000059478-25-000269 · wk-form4_1763501994.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,264.731

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:00 UTC SaleCommon Stock 2,097 $1,031.53 $2,163,110.02
Disclosure

SEC source: 0000316011-25-000075 · form4-11182025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,872,191

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,031.00 to $1,031.75, inclusive.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:00 UTC SaleCommon Stock 7,789 $1,030.45 $8,026,159.47
Disclosure

SEC source: 0000316011-25-000075 · form4-11182025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,874,288

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,030.00 to $1,030.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:26 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0001262388-25-000008 · wk-form4_1763501198.xml · nonDerivative · entry 2

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,948.32

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:26 UTC GrantCommon Stock 4.853 $1,021.70 $4,958.31
Disclosure

SEC source: 0001262388-25-000008 · wk-form4_1763501198.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,732.993

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:12 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0001310215-25-000010 · wk-form4_1763500326.xml · nonDerivative · entry 2

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,378.773

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:12 UTC GrantCommon Stock 11.5 $1,021.70 $11,749.55
Disclosure

SEC source: 0001310215-25-000010 · wk-form4_1763500326.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,163.446

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:17 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0001340823-25-000010 · wk-form4_1763500655.xml · nonDerivative · entry 2

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,240.861

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:17 UTC GrantCommon Stock 9.706 $1,021.70 $9,916.62
Disclosure

SEC source: 0001340823-25-000010 · wk-form4_1763500655.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,025.534

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:13 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0001537067-25-000006 · wk-form4_1763500433.xml · nonDerivative · entry 1

Baicker Katherine · CIK 0001537067 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,502.628

Read SEC document
November 17, 2025 Filed Nov 18, 2025 21:21 UTC GrantCommon Stock 215.327 $1,021.70 $219,999.60
Disclosure

SEC source: 0001551715-25-000006 · wk-form4_1763500905.xml · nonDerivative · entry 1

Kaelin William G Jr · CIK 0001551715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,836.814

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:00 UTC SaleCommon Stock 949 $1,033.16 $980,464.10
Disclosure

SEC source: 0000316011-25-000073 · form4-11172025_041103.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,882,077

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,033.00 to $1,033.39, inclusive.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:00 UTC SaleCommon Stock 17,567 $1,032,319.00 $18,134,747,873.00
Disclosure

SEC source: 0000316011-25-000073 · form4-11172025_041103.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,883,026

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,032.00 to $1,032.95, inclusive.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:00 UTC SaleCommon Stock 55,908 $1,031,414.00 $57,664,293,912.00
Disclosure

SEC source: 0000316011-25-000073 · form4-11172025_041103.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,900,593

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,031.00 to $1,031.99, inclusive.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:00 UTC SaleCommon Stock 103,871 $1,030.31 $107,019,537.75
Disclosure

SEC source: 0000316011-25-000073 · form4-11172025_041103.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,956,501

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,030.00 to $1,030.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3) and (4) to this Form 4.

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:14 UTC
Zakrowski Donald ASVP, Finance, & CAO
SaleCommon Stock 1,000 $1,010.50 $1,010,500.00
Disclosure

SEC source: 0001561539-25-000006 · wk-form4_1763068481.xml · nonDerivative · entry 1

Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,839.659

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2024.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 21:00 UTC SaleCommon Stock 1,360 $1,031.78 $1,403,216.72
Disclosure

SEC source: 0000316011-25-000071 · form4-11142025_041101.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,060,372

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,031.58 to $1,032.14, inclusive.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 21:00 UTC SaleCommon Stock 45,246 $1,030.21 $46,612,881.66
Disclosure

SEC source: 0000316011-25-000071 · form4-11142025_041101.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,061,732

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,030.00 to $1,030.96, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 842 $1,021.07 $859,736.73
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 20

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,106,978

F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,020.664 to $1,021.661, inclusive.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 1,281 $1,019.92 $1,306,516.24
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 19

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,107,820

F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,019.651 to $1,020.375 inclusive.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 7,833 $1,018.83 $7,980,487.56
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 18

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,109,101

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,018.65 to $1,019.421, inclusive.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 47,073 $1,018.02 $47,921,349.61
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 17

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,116,934

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,017.63 to $1,018.62, inclusive.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 7,188 $1,017.16 $7,311,317.33
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 16

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,164,007

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,016.60 to $1,017.54, inclusive.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:00 UTC SaleCommon Stock 13,415 $1,016.01 $13,629,707.08
Disclosure

SEC source: 0000316011-25-000069 · form4-11132025_041101.xml · nonDerivative · entry 15

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,171,195

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,015.59 to $1,016.439, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.